Who's afraid of Ozempic? From restaurants to package makers, companies work to calm investors' GLP-1 jitters. MarketWatch Nov 10, 2023 4:13pm
U.S. stocks score fourth day of gains after Fed minutes, wholesale inflation data MarketWatch Oct 11, 2023 8:34pm
Dialysis-company stocks slide after Ozempic trial's success in treating kidney disease MarketWatch Oct 11, 2023 2:54pm
Fresenius Shares Slump After Novo Nordisk Kidney Disease Trial Shows Efficacy Global News Select Oct 11, 2023 9:38am